Betulinic Acid Reduces Intestinal Inflammation and Enhances Intestinal Tight Junctions by Modulating the PPAR-γ/NF-κB Signaling Pathway in Intestinal Cells and Organoids
Nutrients · 2025
DOI: 10.3390/nu17132052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Xu Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical Science, Dalian Medical University, Dalian 116044, China. Hauptthemen laut MEDLINE: Pentacyclic Triterpenes, NF-kappa B, Organoids, PPAR gamma. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Key R&D Program for International Science and Technology Cooperation Projects, Youth Talent Cultivation Fund Project of Dalian Medical University, National Key R&D Program for International Science and Technology Cooperation Projects.
Abstract (Originalsprache)
Background
Intestinal epithelial barrier (IEB) dysfunction is related to multiple gastrointestinal disorders, notably inflammatory bowel disease (IBD). Betulinic acid (BA), a compound derived from birch bark, has demonstrated potential therapeutic benefits in IBD. Nevertheless, the impact of BA on IEB function has not been fully elucidated.
Methods
The current study aimed to explore the potential underlying mechanisms of BA in dextran sodium sulfate (DSS)-induced IBD in mice and co-culture models involving Caco-2/HT29-MTX-E12 cell monolayers or mouse intestinal organoids (IOs) in conjunction with macrophages stimulated by lipopolysaccharide (LPS).
Results
In vivo, BA treatment significantly improved body weight and colon length, alleviated disease activity index (DAI) scores, and reduced colonic histopathological injury in IBD mice. In vitro, BA reduced the flux of FITC-dextran; increased the TEER; and decreased the production of IL-6, IL-1β, and TNF-α while increasing IL-10 mRNA levels. Additionally, BA enhanced IEB formation by upregulating ZO-1, occludin (OCLN), and claudin-1 (CLDN1). Molecular docking studies revealed significant docking scores and interactions between BA and PPAR-γ. Moreover, BA significantly upregulated PPAR-γ protein expression, decreased NF-κB and MLC2 phosphorylation, and reduced MLCK protein expression. However, this effect was reversed by GW9662, an effective PPAR-γ antagonist.
Conclusions
The findings reveal that BA mitigates IBD by safeguarding the intestinal barrier against dysfunction. This effect may be attributed to its ability to suppress inflammation and enhance the expression of tight junction proteins by modulating the PPAR-γ/NF-κB signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Basic Medical Science, Dalian Medical University, Dalian 116044, China.
- Advanced Institute for Medical Sciences, Dalian Medical University, Dalian 116044, China.
Förderung
- The National Key R&D Program for International Science and Technology Cooperation Projects
- Youth Talent Cultivation Fund Project of Dalian Medical University
- National Key R&D Program for International Science and Technology Cooperation Projects
Zitieren
APA
Zheng, X., Cao, Z., Wang, M., Yuan, R., Han, Y., Li, A., & Wang, X. (2025). Betulinic Acid Reduces Intestinal Inflammation and Enhances Intestinal Tight Junctions by Modulating the PPAR-γ/NF-κB Signaling Pathway in Intestinal Cells and Organoids. Nutrients. https://doi.org/10.3390/nu17132052
Vancouver
Zheng X, Cao Z, Wang M, Yuan R, Han Y, Li A, et al. Betulinic Acid Reduces Intestinal Inflammation and Enhances Intestinal Tight Junctions by Modulating the PPAR-γ/NF-κB Signaling Pathway in Intestinal Cells and Organoids. Nutrients. 2025. doi:10.3390/nu17132052
BibTeX
@article{Zheng2025,
author = {Zheng, Xu and Cao, Zhen and Wang, Mingqi and Yuan, Ruqiang and Han, Yinhe and Li, Ang and Wang, Xiuli},
title = {Betulinic Acid Reduces Intestinal Inflammation and Enhances Intestinal Tight Junctions by Modulating the PPAR-γ/NF-κB Signaling Pathway in Intestinal Cells and Organoids},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17132052}
}
EUVIMED